(2
Ketamine
N-methyl-d-aspartate receptors
antidepressant
hydroxynorketamine
long-term potentiation
Journal
Brain and neuroscience advances
ISSN: 2398-2128
Titre abrégé: Brain Neurosci Adv
Pays: United States
ID NLM: 101702599
Informations de publication
Date de publication:
Historique:
received:
01
05
2020
accepted:
20
08
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
23
10
2020
Statut:
epublish
Résumé
The ketamine metabolite (2
Identifiants
pubmed: 33088919
doi: 10.1177/2398212820957847
pii: 10.1177_2398212820957847
pmc: PMC7545754
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2398212820957847Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Références
Nature. 1993 Jan 7;361(6407):31-9
pubmed: 8421494
Neuropharmacology. 2017 Jan;112(Pt A):144-149
pubmed: 27520396
J Neurosci. 2009 Mar 4;29(9):2774-9
pubmed: 19261873
Pharmacol Rev. 2018 Jul;70(3):621-660
pubmed: 29945898
Mol Brain. 2020 Jun 16;13(1):92
pubmed: 32546197
Neuropharmacology. 2018 Nov;142:30-40
pubmed: 29885421
Neuropsychopharmacology. 2018 Jan;43(1):221-222
pubmed: 29192654
Biol Psychiatry. 2000 Feb 15;47(4):351-4
pubmed: 10686270
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5160-5169
pubmed: 30796190
J Physiol. 1983 Jan;334:33-46
pubmed: 6306230
Nature. 2018 Feb 14;554(7692):317-322
pubmed: 29446381
Nature. 2016 May 04;533(7604):481-6
pubmed: 27144355
Biol Psychiatry. 2017 Apr 15;81(8):e65-e67
pubmed: 27817845
Nature. 2011 Jun 15;475(7354):91-5
pubmed: 21677641
Brain Res. 1983 Jan 3;258(1):159-64
pubmed: 24010182
Br J Pharmacol. 1983 Jun;79(2):565-75
pubmed: 6317114